WARFARIN DOSING ALGORITHM REFINEMENTS AFTER 7-9 DAYS OF THERAPY BASED ON PHARMACOGENETIC, PHARMACOKINETIC, CLINICAL, AND LABORATORY DATA

被引：0
|
作者：
Horne, Benjamin D.
Lenzini, Petra A.
Wadelius, Mia
Jorgensen, Andrea L.
Kimmel, Stephen E.
Eriksson, Niclas
Anderson, Jeffrey L.
Pirmohamed, Munir
Limdi, Nita A.
Burmester, James K.
Kurnik, Daniel
Stein, Charles M.
Caldwell, Michael D.
Eby, Charles S.
Rane, Anders
Lindh, John D.
Shin, Jae-Gook
Kim, Ho-Sook
Angchaisuksiri, Pantep
Chen, Jinbo
Carlquist, John F.
Grice, Gloria R.
Kronquist, Kathryn E.
Gage, Brian F.
机构：
[1] Intermt Med Ctr, Murray, UT USA
[2] Univ Utah, Salt Lake City, UT USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2010年 / 55卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1028-160
引用
收藏
页数：1
相关论文
共 9 条
  • [1] Warfarin dosing algorithm using clinical, demographic and pharmacogenetic data from Chinese patients
    Joyce H. S. You
    Raymond S. M. Wong
    Mary M. Y. Waye
    Yawei Mu
    Cadmon K. Lim
    Kai-chow Choi
    Gregory Cheng
    [J]. Journal of Thrombosis and Thrombolysis, 2011, 31 : 113 - 118
  • [2] Warfarin dosing algorithm using clinical, demographic and pharmacogenetic data from Chinese patients
    You, Joyce H. S.
    Wong, Raymond S. M.
    Waye, Mary M. Y.
    Mu, Yawei
    Lim, Cadmon K.
    Choi, Kai-chow
    Cheng, Gregory
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2011, 31 (01) : 113 - 118
  • [3] Proposal of a pharmacogenetic-based dosing algorithm for the induction of warfarin anticoagulation therapy in patients with thromboembolic disease
    Avery, Peter
    Pirmohamed, Munir
    Jorgensen, Andrea
    Kamali, Farhad
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (02) : 291 - 291
  • [4] Clinical benefits of pharmacogenetic algorithm-based warfarin dosing: meta-analysis of randomized controlled trials
    Li, Xiaoqi
    Yang, Jie
    Wang, Xuyun
    Xu, Qiang
    Zhang, Yuxiao
    Yin, Tong
    [J]. THROMBOSIS RESEARCH, 2015, 135 (04) : 621 - 629
  • [5] Clinical benefits of pharmacogenetic algorithm-based warfarin dosing: Meta-analysis of randomized controlled trials: Comment
    Belley-Cote, Emilie P.
    Whitlock, Richard P.
    French, Benjamin
    Evaniew, Nathan
    Kimmel, Stephen E.
    [J]. THROMBOSIS RESEARCH, 2015, 136 (01) : 180 - 181
  • [6] Clinical Application of Pharmacogenetic-Based Warfarin-Dosing Algorithm in Patients of Han Nationality after Rheumatic Valve Replacement: A Randomized and Controlled Trial
    Wang, MingSong
    Lang, XiLong
    Cui, ShiTao
    Fei, Ke
    Zou, LiangJian
    Cao, Jia
    Wang, LiangXu
    Zhang, ShengHui
    Wu, XinTian
    Wang, YiLing
    Ji, Qiang
    [J]. INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2012, 9 (06): : 472 - 479
  • [7] Pharmacogenetic dosing algorithm based on CYP2C9 genotypes for the quantitative determination of initial warfarin dose and dose adjustments
    Horne, BD
    Carlquist, JF
    Muhlestein, JB
    Lappé, DL
    James, BC
    Renlund, DG
    Clarke, JL
    Walker, JE
    Pearson, RR
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 334A - 334A
  • [8] Warfarin and miconazole oral gel interactions: analysis and therapy recommendations based on clinical data and a pharmacokinetic model
    Miki, A.
    Ohtani, H.
    Sawada, Y.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2011, 36 (06) : 642 - 650
  • [9] ACENOCOUMAROL DOSING ALGORITHM INCLUDING CLINICAL, DEMOGRAPHIC AND PHARMACOGENETIC DATA (CYP2C9, VKORC1, CYP4F2 AND APOE) FOR USE IN PATIENTS WITH THE THROMBOEMBOLIC DISEASE
    Borobia, A. M.
    Lubomirov, R.
    Ramirez, E.
    Lorenzo, A.
    Campos, A.
    Fernandez-Capitan, C.
    Frias, J.
    Carcas, A. J.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 28 - 28
1